Key result
Commercially available Lp(a) test kits suffer from lack of standardization and cross-reactivity, explaining why some studies failed to detect the association between high Lp(a) and CHD.
Design
Review
Authors
Loading...
Current Lp(a) assays should not guide decisions; leaves open the true CHD association pending standardization.
Methodological issues with Lp(a) test kits, such as lack of standardization and isoform variation, may explain conflicting results regarding Lp(a) as a CHD risk factor.
Kåre Berg (1994) conducted a review in Coronary heart disease. Lp(a) lipoprotein test kits was evaluated. Commercially available Lp(a) test kits suffer from lack of standardization and cross-reactivity, explaining why some studies failed to detect the association between high Lp(a) and CHD.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: